Kyntra Bio, Inc. SEC filings KYNB
Kyntra Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 18, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 10, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | May 3, 2022 | — |
| CORRESP | Letter to the SEC | Feb 11, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2022 | — |
| CORRESP | Letter to the SEC | Jan 20, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2022 | — |
| CORRESP | Letter to the SEC | Dec 16, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 29, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 1, 2021 | — |
| CT ORDER | Filing | Sep 18, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2020 | — |
| CORRESP | Letter to the SEC | Feb 21, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2020 | — |
| CORRESP | Letter to the SEC | Jan 31, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2019 | — |
| CORRESP | Letter to the SEC | Dec 13, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Sep 4, 2019 | — |
| CT ORDER | Filing | Nov 8, 2018 | — |
| CT ORDER | Filing | Oct 9, 2018 | — |
| CT ORDER | Filing | Dec 22, 2017 | — |
| CT ORDER | Filing | Dec 8, 2017 | — |
| CT ORDER | Filing | Jul 31, 2017 | — |
| CT ORDER | Filing | Jun 1, 2017 | — |
| CT ORDER | Filing | Mar 8, 2017 | — |
| CT ORDER | Filing | Dec 20, 2016 | — |
| CT ORDER | Filing | Aug 19, 2016 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KYNB (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 921299
- Former names
- FIBROGEN INC (until Jan 7, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.